Follow the 아스타 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 아스타 has logged 69 reports. Market capitalisation: €99.4bn. The latest transaction was disclosed on 23 June 2026 (Other). Among the most active insiders: 품에자산운용. Every trade is openly available.
69
Insider Decl.
n/a
Thresholds
n/a
49 ops.
Buy Volume
n/a
n/a
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,009 of 29,063 companies
31.3
score / 100
Value
26
Quality
37
FCF yld-3.4%
Earn yld-3.3%
EV/EBITDA·
ROE-50%
Gross mgn48%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
아스타 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and commercialization of innovative pharmaceutical products.